Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Osteoporosis Reports
Published in: Current Osteoporosis Reports 6/2016

01-12-2016 | Regenerative Biology and Medicine in Osteoporosis (T Webster, Section Editor)

In Situ Sensor Advancements for Osteoporosis Prevention, Diagnosis, and Treatment

Authors: Luting Liu, Thomas J. Webster

Published in: Current Osteoporosis Reports | Issue 6/2016

Login to get access

Abstract

Osteoporosis is still a serious issue in healthcare, and will continue to increase due to the aging and growth of the population. Early diagnosis is the key to successfully treating many diseases. The earlier the osteoporosis is diagnosed, the more quickly people can take action to stop bone deterioration. Motivated by this, researchers and companies have begun developing smart in situ bone sensors in order to dramatically help people to monitor their bone mass density (BMD), bone strain or bone turnover markers (BTMs); promptly track early signs of osteoporosis; and even monitor the healing process following surgery or antiresorptive therapy. This paper focuses on the latest advancements in the field of bone biosensing materials and sensor technologies and how they can help now and in the future to detect disease and monitor bone health.
Literature
1.
2.
3.
• Cosman F, Beur SJD, LeBoff MS, Lewiecki EM, Tanner B, Randall S, et al. Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2014;25:2359–81. The clinician’s guide to prevention and treatment of osteoporosis developed by several experts in the field of bone health offers concise recommendations regarding prevention, risk assessment, diagnosis, and treatment of osteoporosis in postmenopausal women and men based on the most common existing diagnostic and treatment methods.CrossRefPubMedPubMedCentral
4.
Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res. 2007;22:465–75.CrossRefPubMed
5.
6.
Barozzi N, Peeters GM, Tett SE. Actions following adverse drug events—how do these influence uptake and utilisation of newer and/or similar medications? BMC Health Serv Res. 2015;15:498.CrossRefPubMedPubMedCentral
7.
8.
López-López J, Estrugo-Devesa A, Jane-Salas E, Ayuso-Montero R, Gómez-Vaquero C. Early diagnosis of osteoporosis by means of orthopantomograms and oral x-rays: a systematic review. Med Oral Patol Oral Cir Bucal. 2011;16:e905–13.CrossRefPubMed
9.
Bartl R, Frisch B. Osteoporosis: diagnosis, prevention, therapy. Berlin: Springer; 2009. ISBN: 978-3-540-79526-1 (Print) 978-3-540-79527-8 (Online).CrossRef
10.
Miller PD, Zapalowski C, Kulak CA, Bilezikian JP. Bone densitometry: the best way to detect osteoporosis and to monitor therapy. J Clin Endocrinol Metab. 1999;84:1867–71.CrossRefPubMed
11.
Engelke K, Adams JE, Armbrecht G, Augat P, Bogado CE, Bouxsein ML, et al. Clinical use of quantitative computed tomography and peripheral quantitative computed tomography in the management of osteoporosis in adults: the 2007 ISCD Official Positions. J Clin Densitom. 2008;11:123–62.CrossRefPubMed
12.
13.
Majumdar S. Magnetic resonance imaging for osteoporosis. Skelet Radiol. 2008;37:95–7.CrossRef
14.
Benitez CL, Schneider DL, Barrett-Connor E, Sartoris DJ. Hand ultrasound for osteoporosis screening in postmenopausal women. Osteoporos Int. 2000;11:203–10.CrossRefPubMed
15.
•• Khashayar P, Amoabediny G, Larijani B, Vanfleteren J. Bone biosensors: knowing the present and predicting the future. J Micromech Microeng. 2016;26:023002. Paper reviews the latest advancements in the field of bone biosensing technologies in three main categories: biomechanical sensors, multiplex automated assays, label-free biosensors.CrossRef
16.
Ledet EH, D’Lima D, Westerhoff P, Szivek JA, Wachs RA, Bergmann G. Implantable sensor technology: from research to clinical practice. J Am Acad Orthop Surg. 2012;20:383–92.CrossRefPubMed
17.
Sattler M, Clauss J, Schmidhuber M, Belsky J, Wolf B. Implantable sensor system for the monitoring of bone healing. IFMBE Proc. 2009;25:281–4.CrossRef
18.
Bassi AS, Knopf GK. Smart biosensor technology. Boca Raton: CRC Press; 2006. ISBN: 978-0-8493-3759-8 (print) 978-1-4200-1950-6 (online).CrossRef
19.
Malik P, Katyal V, Malik V, Asatkar A, Inwati G, Mukherjee TK. Nanobiosensors: concepts and variations. ISRN Nanomaterials. 2013; 327435.
20.
21.
Webster TJ. Nanotechnology enabled in situ sensors for monitoring health. New York: Springer; 2011. ISBN: 978-1-4419-7290-3 (Print) 978-1-4419-7291-0 (Online).CrossRef
22.
Tran N, Webster TJ. Nanotechnology for bone materials. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009;1:336–51.CrossRefPubMed
23.
24.
25.
Lee J, Vasikaran S. Current recommendations for laboratory testing and use of bone turnover markers in management of osteoporosis. Ann Lab Med. 2012;32:105–12.CrossRefPubMedPubMedCentral
26.
Bieglmayer C, Dimai HP, Gasser RW, Kudlacek S, Obermayer-Pietsch B, Woloszczuk W, et al. Biomarkers of bone turnover in diagnosis and therapy of osteoporosis: a consensus advice from an Austrian working group. Wien Med Wochenschr. 2012;162:464–77.CrossRefPubMed
27.
Klein-Nulend J, Bakker AD, Bacabac RG, Vatsa A, Weinbaum S. Mechanosensation and transduction in osteocytes. Bone. 2013;54:182–90.CrossRefPubMed
28.
• Wheater G, Elshahaly M, Tuck SP, Datta HK, van Laar JM. The clinical utility of bone marker measurements in osteoporosis. J Transl Med. 2013;11:201. This paper focuses on identification of specific biomarkers (i.e. specific marker of bone resorption (CTX) and bone formation (P1NP)) and utilization of bone marker measurements for the clinical management of osteoporosis and other bone diseases.CrossRefPubMedPubMedCentral
29.
Grieshaber D, MacKenzie R, Vörös J, Reimhult E. Electrochemical biosensors—sensor principles and architectures. Sensors. 2008;8:1400–58.CrossRefPubMedCentral
30.
Wang Y, Vaddiraju S, Gu B, Papadimitrakopoulos F, Burgess DJ. Foreign body reaction to implantable biosensors: effects of tissue trauma and implant size. J Diabetes Sci Technol. 2015;9:966–77.CrossRefPubMedPubMedCentral
31.
Karp FB, Bernotski NA, Valdes TI, Bohringer KF. Foreign body response investigated with an implanted biosensor by in situ electrical impedance spectroscopy. IEEE Sensors J. 2008;8:104–12.CrossRef
32.
•• Luz RAS, Iost RM, Crespilho FN. Nanomaterials for biosensors and implantable biodevices. Nanobioelectrochemistry. Berlin Heidelberg: Springer; 2013. p. 27–48. This book chapter focuses on utilization of biological molecules (i.e. enzymes, nucleotides, antigens, DNA, aminoacids) in conjunction with nanostructured materials (i.e. nanoparticlebased materials and carbon materials) for development of miniaturized devices and implantable biosensors for real time monitoring.
33.
Eastell R, Hannon RA. Biomarkers of bone health and osteoporosis risk. Proc Nutr Soc. 2008;67:157–62.CrossRefPubMed
34.
Halleen JM, Alatalo SL, Janckila AJ, Woitge HW, Seibel MJ, Väänänen HK. Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption. Clin Chem. 2001;47:597–600.PubMed
35.
Hysi L, Rexha T. Serum osteocalcin as a specific marker of bone turnover in postmenopausal women. Albanian J Agric Sci Suppl Special Edition. 2014:341-344.
36.
Jagtap VR, Ganu JV, Nagane NS. BMD and serum intact osteocalcin in postmenopausal osteoporosis women. Indian J Clin Biochem. 2011;26:70–3.CrossRefPubMed
37.
• Ji X, Chen X, Yu X. MicroRNAs in osteoclastogenesis and function: potential therapeutic targets for osteoporosis. Int J Mol Sci. 2016;17:349. This paper containts a summary of microRNAs, presents our current understanding of how microRNAs regulate osteoclastogenesis, and discusses their potential clinical implications, such as biomarkers and the development of new drugs for osteoporosis.CrossRefPubMedPubMedCentral
38.
Wang Y, Li L, Moore BT, Peng X-H, Fang X, Lappe JM, et al. MiR-133a in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis. PLoS One. 2012;7:e34641.CrossRefPubMedPubMedCentral
39.
Cao Z, Moore BT, Wang Y, Peng XH, Lappe JM, Recker RR, et al. MiR-422a as a potential cellular microRNA biomarker for postmenopausal osteoporosis. PLoS One. 2014;9:e97098.CrossRefPubMedPubMedCentral
40.
Purroy J, Spurr NK. Molecular genetics of calcium sensing in bone cells. Mol Genet. 2002;11:2377–84.
41.
Marie PJ. The calcium-sensing receptor in bone cells: a potential therapeutic target in osteoporosis. Bone. 2010;46:571–6.CrossRefPubMed
42.
McCormick RK. Osteoporosis: integrating biomarkers and other diagnostic correlates into the management of bone fragility. Altern Med Rev. 2007;12:113–45.PubMed
43.
Melik R, Perkgoz NK, Unal E, Puttlitz C, Demir HV. Bio-implantable passive on-chip RF-MEMS strain sensing resonators for orthopaedic applications. J Micromech Microeng. 2008;18:115017.CrossRef
44.
Domb AJ, Khan W. Focal controlled drug delivery. Adv Deliv Sci Tech. 2014; 33-59. ISBN: 978-1-4614-9433-1 (Print) 978-1-4614-9434-8 (Online).
45.
Hermawan H, Ramdan D, Djuansjah JRP. Metals for biomedical applications, biomedical engineering - from theory to applications, Prof. Reza Fazel (Ed.), InTech. 2011; 412-430. ISBN 978-953-307-637-9.
46.
Thamaraiselvi TV, Rajeswari S. Biological evaluation of bioceramic materials—a review. Trends Biomater Artif Organs. 2004;18:9–17.
47.
Qina Y, Howladera MMR, Deena MJ, Haddaraa YM, Selvaganapathyb PR. Polymer integration for packaging of implantable sensors. Sensors Actuat B. 2014;202:758–78.CrossRef
48.
Albert K, Schledjewski R, Harbaugh M, Bleser S, Jamison R, Friedrich K. Characterization of wear in composite material orthopaedic implants. Part II: the implant/bone interface. Biomed Mater Eng. 1994;4:199–211.PubMed
49.
•• Wujcik EK, Monty CN. Nanotechnology for implantable sensors: carbon nanotubes and graphene in medicine. WIREs Nanomed Nanobiotechnol. 2013;5:233–49. This paper specifically focuses on implantable sensors equipped with nanostructured carbon allotropes, such as carbon nanotubes or graphene for nanomedicine and nanobiotechnology.CrossRef
50.
51.
Patil M, Ramanathan M, Shanov V, Kumta PN. Carbon nanotube-based impedimetric biosensors for bone marker detection. In: Matyáš J, Ohji T, Pickrell G, Wong-Ng W, Kanakala R, editors. Advances in materials science for environmental and energy technologies IV: ceramic transactions, vol. 253. Hoboken: Wiley; 2015. doi:10.​1002/​9781119190042.​ch18.
52.
Sirivisoot S, Webster TJ. In situ bone growth detection using carbon nanotubes-titanium sensors. Bio Nano Sci. 2013;3:184–91.
53.
Bao Q, Loh KP. Graphene photonics, plasmonics, and broadband optoelectronic devices. ACS Nano. 2012;6:3677–94.CrossRefPubMed
54.
Sirivisoot S, Parcharoen Y, Webster TJ. Electrochemical detection of bacteria using graphene oxide electrodeposited on titanium implants. Adv Sci Tech. 2014;96:45–53.CrossRef
55.
Kang X, Wang J, Wu H, Aksay IA, Liu J, Lin Y. Glucose oxidase-graphene-chitosan modified electrode for direct electrochemistry and glucose sensing. Biosens Bioelectron. 2009;25:901–5.CrossRefPubMed
56.
Heo C, Yoo J, Lee S, Jo A, Jung S, Yoo H, et al. The control of neural cell-to-cell interactions through non-contact electrical field stimulation using graphene electrodes. Biomaterials. 2011;32:19–27.CrossRefPubMed
57.
Haque A-MJ, Park H, Sung D, Jon S, Choi SY, Kim K. An electrochemically reduced graphene oxidebased electrochemical immunosensing platform for ultrasensitive antigen detection. Anal Chem. 2012;84:1871–8.CrossRefPubMed
58.
59.
Chung YM, Liu YC. Biosensor and method for bone mineral density measurement. U.S. Patent 7544327 B2, 2009.
60.
Kuballa J, Schüzb J, Gamma H, Webera M. Bone marrow punctures and pain. Acute Pain. 2004;6:9–14.CrossRef
61.
Parmar BJ, Longsine W, Sabonghy EP, Han A, Tasciotti E, Weiner BK, et al. Characterization of controlled bone defects using 2D and 3D ultrasound imaging techniques. Phys Med Biol. 2010;55:4839–59.CrossRefPubMed
62.
Alfaro F, Weiss L, Campbell P, Miller M, Fedder GK. Design of a multi-axis implantable MEMS sensor for intraosseous bone stress monitoring. J Micromech Microeng. 2009;19:085016.CrossRef
63.
Tan EL, Pereles BD, Horton B, Shao R, Zourob M, Ong KG. Implantable biosensors for real-time strain and pressure monitoring. Sensors. 2008;8:6396–406.CrossRefPubMedPubMedCentral
64.
Alamusi, Hu N, Fukunaga H, Atobe S, Liu Y, Li J. Piezoresistive strain sensors made from carbon nanotubes based polymer nanocomposites. Sensors. 2011;11:10691–723.CrossRefPubMedPubMedCentral
65.
Wen YH, Yang GY, Bailey VJ, Lin G, Tang WC, Keyak JH. Mechanically robust micro-fabricated strain gauges for use on bones. Proc. 3rd Annual Int. IEEE EMBS Special Topic Conf. Microtechnologies in Med. and Biol. 2005; 302-304.
66.
Pang C, Lee GY, Kim T, Kim SM, Kim HN, Ahn SH, et al. A flexible and highly sensitive strain-gauge sensor using reversible interlocking of nanofibres. Nat Mater. 2012;11:795–801.CrossRefPubMed
67.
Dharap P, Li Z, Nagarajaiah S, Barrera EV. Nanotube film based on single-wall carbon nanotubes for strain sensing. Nanotechnology. 2004;15:379–82.CrossRef
68.
Singh P, Rai HM. Performance analysis of photometric strain biosensor for bones using artificial neural network. Int J Comput Appl. 2012;54:8.
69.
Singh P, Shrivastava A. Optical biosensor based on microbendings technique: an optimized mean to measure the bone strength. Adv Opt Technol. 2014; 853725.
70.
Fresvig T, Ludvigsen P, Steen H, Reikerås O. Fibre optic Bragg grating sensors: an alternative method to strain gauges for measuring deformation in bone. Med Eng Phys. 2008;30:104–8.CrossRefPubMed
71.
Shrivastava S, Prakash R. Assessment of bone condition by acoustic emission technique: a review. J Biomed Sci Eng. 2009;2:144–54.CrossRef
72.
Lentle BC, Aldrich JE, Akhtar A. Diagnosis of osteoporosis using acoustic emissions. U.S. Patent 6024711 A, 2000.
73.
Aggelis DG, Strantza M, Louis O, Boulpaep F, Polyzos D, Hemelrijck DV. Fracture of human femur tissue monitored by acoustic emission sensors. Sensors. 2015;15:5803–19.CrossRefPubMedPubMedCentral
74.
75.
76.
Li CM, Dong H, Cao X, Luong JH, Zhang X. Implantable electrochemical sensors for biomedical and clinical applications: progress, problems, and future possibilities. Curr Med Chem. 2007;14:937–51.CrossRefPubMed
77.
Sirivisoot S, Webster TJ. Multiwalled carbon nanotubes enhance electrochemical properties of titanium to determine in situ bone formation. Nanotechnology. 2008;19:295101.CrossRefPubMed
78.
Sirivisoot S, Pareta R, Webster TJ. Electrically controlled drug release from nanostructured polypyrrole coated on titanium. Nanotechnology. 2011;22:085101.CrossRefPubMed
79.
Dvorak MM, Siddiqua A, Ward DT, Carter DH, Dallas SL, Nemeth EF, et al. Physiological changes in extracellular calcium concentration directly control osteoblast function in the absence of calciotropic hormones. Proc Natl Acad Sci U S A. 2004;101:5140–5.CrossRefPubMedPubMedCentral
80.
Caglar P, Tuncel SA, Malcik N, Landers JP, Ferrance JP. A microchip sensor for calcium determination. Anal Bioanal Chem. 2006;386:1303–12.CrossRefPubMed
81.
Widler L. Calcilytics: antagonists of the calcium-sensing receptor for the treatment of osteoporosis. Future Med Chem. 2011;3:535–47.CrossRefPubMed
82.
Zhang L, Liu L, Xia N. Electrochemical sensing of alkaline phosphatase activity based on difference of surface charge of electrode. Int J Electrochem Sci. 2013;8:8311–9.
83.
84.
Bhalla S, Baja S. Bone characterization using piezotransducers as biomedical sensors. Strain. 2008;44:475–8.CrossRef
85.
Levine AG. Biosystems nanotechnology: big opportunities in the science of the small. Science. 2014;346:870–3.CrossRef
86.
Metadata
Title
In Situ Sensor Advancements for Osteoporosis Prevention, Diagnosis, and Treatment
Authors
Luting Liu
Thomas J. Webster
Publication date
01-12-2016
Publisher
Springer US
Published in
Current Osteoporosis Reports / Issue 6/2016
Print ISSN: 1544-1873
Electronic ISSN: 1544-2241
DOI
https://doi.org/10.1007/s11914-016-0339-7

Other articles of this Issue 6/2016

Current Osteoporosis Reports 6/2016 Go to the issue

Bone and Diabetes (A Schwartz and P Vestergaard, Section Editors)

Bone Microarchitecture in Type 1 Diabetes: It Is Complicated

Bone and Diabetes (A Schwartz and P Vestergaard, Section Editors)

Effects of Incretin-Based Therapies and SGLT2 Inhibitors on Skeletal Health

Bone and Diabetes (A Schwartz and P Vestergaard, Section Editors)

Advanced Glycation End Products, Diabetes, and Bone Strength

Craniofacial Skeleton (E Roberts, Section Editor)

Osteoporosis and Periodontitis

Craniofacial Skeleton (G Roberts, Section Editor)

Bone Response of Loaded Periodontal Ligament

Bone and Diabetes (A Schwartz and P Vestergaard, Section Editors)

Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts